BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1751407)

  • 1. A melanoma octamer binding protein is responsive to differentiating agents.
    Sturm RA; Bisshop F; Takahashi H; Parsons PG
    Cell Growth Differ; 1991 Oct; 2(10):519-24. PubMed ID: 1751407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced level of octamer binding transcription factor (Oct-1) is correlated with H2B histone gene repression during differentiation of HL-60 cells by all-trans retinoic acid.
    Kim KY; Kweon KR; Lee MS; Kwak ST; Kim KE; Hwang BD; Lim K
    Biochem Biophys Res Commun; 1995 Aug; 213(2):616-24. PubMed ID: 7646519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
    Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
    Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells.
    Rosfjord E; Rizzino A
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1795-802. PubMed ID: 7945330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A B-cell coactivator of octamer-binding transcription factors.
    Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
    Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
    Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
    Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of the Oct-2 protein during cell differentiation in vivo and in vitro].
    Pankratova EV; Sytina EV; Stepchenko AG
    Mol Biol (Mosk); 1993; 27(4):817-26. PubMed ID: 8361489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel octamer regulatory element in the VH11 leader exon of B-1 cells.
    Goodglick L; Felsher DW; Neshat MS; Braun J
    J Immunol; 1995 May; 154(9):4546-56. PubMed ID: 7722308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human B-cell malignant lymphomas is independent of the octamer lymphoid specific binding factor (Oct-2).
    Kossakowska AE; Urbanski SJ
    Immunology; 1991 Sep; 74(1):37-43. PubMed ID: 1937571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
    Eisen T; Easty DJ; Bennett DC; Goding CR
    Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
    Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
    Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element.
    Sterling K; Bresnick E
    Mol Pharmacol; 1996 Feb; 49(2):329-37. PubMed ID: 8632766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the transcription factor Oct-1 in response to DNA damage.
    Zhao H; Jin S; Fan F; Fan W; Tong T; Zhan Q
    Cancer Res; 2000 Nov; 60(22):6276-80. PubMed ID: 11103783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxidation and reduction on the binding of transcription factors to cis-regulatory elements located in the FGF-4 gene.
    Lickteig K; Lamb K; Brigman K; Rizzino A
    Mol Reprod Dev; 1996 Jun; 44(2):146-52. PubMed ID: 9115711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteins, interacting with the promotor of the immunoglobulin kappa gene].
    Kaznadzeĭ DV; Luchina NN; Stepchenko AG; Polianovskiĭ OL
    Mol Biol (Mosk); 1993; 27(5):1023-31. PubMed ID: 8246925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression.
    Zhang H; Shepherd AT; Eason DD; Wei S; Diaz JI; Djeu JY; Wu GD; Blanck G
    Cell Growth Differ; 1999 Jul; 10(7):457-65. PubMed ID: 10437913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
    Cron RQ; Zhou B; Brunvand MW; Lewis DB
    Genes Immun; 2001 Dec; 2(8):464-8. PubMed ID: 11781715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of octamer transcription factors 1 or 2 alone has no effect on HIV-1 transcription in primary human CD4 T cells.
    Zhang M; Genin A; Cron RQ
    Virology; 2004 Apr; 321(2):323-31. PubMed ID: 15051391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.
    Schreiber E; Merchant RE; Wiestler OD; Fontana A
    Neurosurgery; 1994 Jan; 34(1):129-35. PubMed ID: 8121549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.